| 产品编号 | 图片 | CAS No. | 名称及描述 | 规格 | 价格 | 分子式 | 快速订购 |
|---|---|---|---|---|---|---|---|
| GC46894 |
|
— |
Atropine-d5 - Glpbio |
0 | 需询价 | C17H18D5NO3 | |
| GC46893-10mg |
|
479-20-9 |
Atranorin - Glpbio |
0 | 需询价 | C19H18O8 | |
| GC46893-5mg |
|
479-20-9 |
Atranorin - Glpbio |
0 | 需询价 | C19H18O8 | |
| GC46893-1mg |
|
479-20-9 |
Atranorin - Glpbio |
0 | 需询价 | C19H18O8 | |
| GC46893-500μg |
|
479-20-9 |
Atranorin - Glpbio |
0 | 需询价 | C19H18O8 | |
| GC46892-10mg |
|
1037543-26-2 |
ATRA-BA Hybrid - Glpbio |
0 | 需询价 | C31H40O4 | |
| GC46892-5mg |
|
1037543-26-2 |
ATRA-BA Hybrid - Glpbio |
0 | 需询价 | C31H40O4 | |
| GC46892-1mg |
|
1037543-26-2 |
ATRA-BA Hybrid - Glpbio |
0 | 需询价 | C31H40O4 | |
| GC46891-5mg |
|
— |
ATPA (hydrate) - Glpbio |
0 | 需询价 | C10H16N2O4.XH2O | |
| GC46891-1mg |
|
— |
ATPA (hydrate) - Glpbio |
0 | 需询价 | C10H16N2O4.XH2O | |
| GC46890-1mg |
|
222412-82-0 |
Atorvastatin-d5 (calcium salt) - Glpbio |
0 | 需询价 | C29H30D5FN2O5.1/2Ca | |
| GC46890-500μg |
|
222412-82-0 |
Atorvastatin-d5 (calcium salt) - Glpbio |
0 | 需询价 | C29H30D5FN2O5.1/2Ca | |
| GC46889-50mg |
|
357164-38-6 |
Atorvastatin (calcium salt hydrate) - Glpbio |
0 | 需询价 | C33H34FN2O5.1/2Ca [XH2O] | |
| GC46889-25mg |
|
357164-38-6 |
Atorvastatin (calcium salt hydrate) - Glpbio |
0 | 需询价 | C33H34FN2O5.1/2Ca [XH2O] | |
| GC46889-10mg |
|
357164-38-6 |
Atorvastatin (calcium salt hydrate) - Glpbio |
0 | 需询价 | C33H34FN2O5.1/2Ca [XH2O] | |
| GC46889-5mg |
|
357164-38-6 |
Atorvastatin (calcium salt hydrate) - Glpbio |
0 | 需询价 | C33H34FN2O5.1/2Ca [XH2O] | |
| GC46888-5mg |
|
— |
ATI-2341 (trifluoroacetate salt) - Glpbio |
0 | 需询价 | C104H178N26O25S2.XCF3COOH | |
| GC46888-1mg |
|
— |
ATI-2341 (trifluoroacetate salt) - Glpbio |
0 | 需询价 | C104H178N26O25S2.XCF3COOH | |
| GC46888-500μg |
|
— |
ATI-2341 (trifluoroacetate salt) - Glpbio |
0 | 需询价 | C104H178N26O25S2.XCF3COOH | |
| GC46887-1mg |
|
1092540-50-5 |
Atazanavir-d6 - Glpbio |
0 | 需询价 | C38H46D6N6O7 | |
小泰
|
010-60710855
|